VKTX
#1556
Viking Therapeutics, Inc. - Common Stock
32.4 0 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.75%
Monthly Change
+1.92%
6 month change
-1.76%
Year Change
+20.13%
Previous Close
32.1 6
Open
32.3 6
Low
32.3 2
High
32.4 7
Volume
251
Financials
- Market Capitalization 3.78 B
- Employee 59
- Founded 2012
- CEO Brian Lian
- Website www.vikingtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG006LGV869
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1549 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 33.35 USD | -4.00% | -12.56% | +64.37% | +262.50% | 3.72 B USD | ||
| 1554 |  DNLI Denali Therapeutics Inc. - Common Stock | 23.66 USD | -1.42% | -0.96% | +3.54% | +46.32% | 3.78 B USD | ||
| 1564 |  LEGN Legend Biotech Corporation - American Depositary Shares | 20.47 USD | +2.97% | -2.57% | +10.89% | -35.99% | 3.79 B USD | ||
| 1573 |  RCUS Arcus Biosciences, Inc. Common Stock | 28.69 USD | -1.71% | -6.30% | +2.91% | +171.69% | 3.65 B USD |
Frequently asked questions about Viking Therapeutics, Inc
What is the Viking Therapeutics, Inc stock price today?
The current price of Viking Therapeutics, Inc (VKTX) is 32.40. Over the past 24 hours, the stock has changed by +0.75%. Follow the VKTX chart for real-time price dynamics.
What is the stock ticker of Viking Therapeutics, Inc?
Viking Therapeutics, Inc trades under the ticker VKTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Viking Therapeutics, Inc stock going up?
VKTX has changed by -1.73% over the last week, +1.92% over the last month, and +20.13% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Viking Therapeutics, Inc?
Viking Therapeutics, Inc currently has a market capitalization of 3.78 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Viking Therapeutics, Inc earnings last quarter?
Last quarter, Viking Therapeutics, Inc reported earnings of -1.1 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Viking Therapeutics, Inc revenue for the last quarter?
Viking Therapeutics, Inc reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Viking Therapeutics, Inc net income for the last quarter?
Viking Therapeutics, Inc reported net income of -128.02 M for the last quarter. The previous quarter showed -158.32 M, which means net income changed by +19.14%.
How many employees does Viking Therapeutics, Inc have?
As of the latest available data, Viking Therapeutics, Inc has 59 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Viking Therapeutics, Inc stock?
You can buy Viking Therapeutics, Inc (VKTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Viking Therapeutics, Inc stock?
Investing in Viking Therapeutics, Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VKTX chart and related analysis on metatrader.com as part of your research.